Open Access Journal

Journal of Bioequivalence Studies

ISSN: 2575-551X IF: 2.3* DOI: 10.15744

Email: jbs@annexpublishers.com

Submit Manuscript → Browse Articles Instructions for Authors

Journal at a Glance

Review typeDouble-blind

Target decision~21 days

Submission feeNone

LicenceCC BY 4.0

Word limitsNone

About

About the Journal

Journal of Bioequivalence Studies (JBS) studies is an open access online journal which aims to publish peer reviewed research articles that encompasses a wide range of current research in the field of bioequivalence and offers a promising platform for the authors to make their valuable contributions towards the journal. JBS encompasses the full spectrum of bioequivalence studies including pharmacokinetics, pharmacodynamics, drug delivery, drug discovery, etc.

Why publish with us

Built for researchers

⚡

Fast peer review

Target first decision within 21 days. Double-blind review by 2-3 field experts.

🔓

Fully open access

All articles CC BY 4.0. No paywalls. Compliant with funder mandates worldwide.

🔗

DOI & indexing

Every article receives a unique DOI. Indexed in PubMed, Google Scholar, CrossRef.

🚀

Rapid publication

Published within 7 days of acceptance. No unnecessary delays in dissemination.

🌐

Global & equitable

Readers in 170+ countries. Waiver program available for authors from developing nations.

📈

No content limits

No word limits. Multiple article formats: research, reviews, case reports, short communications.

How it works

Simple. Transparent. Streamlined.

Submit

Upload your manuscript via our online portal. Quality check within 48 hours.

Review

Double-blind peer review by 2-3 field experts. Target decision: ~21 days.

Revise

Constructive feedback from reviewers. Dedicated editorial support throughout.

Publish

Published within 7 days. DOI assigned via CrossRef. Globally indexed.

Submit Manuscript →

Highlights

Research Highlights

Interaction of Citrinin with Human Serum Albumin

Citrinin (CIT) is a mycotoxin produced by several Aspergillus, Penicillium, and Monascus species. CIT occurs worldwide in different foods and drinks and causes health problems for humans and animals.

Comparative Pharmacokinetics Study of Icariin and Icariside II in Rats

To explore the pharmacokinetic properties of icariin (ICA) and icariside II (ICA II) following intragastric and intravenous administration in rats, a rapid and sensitive method.

Effect of Resveratrol Treatment on the Pharmacokinetics of Diclofenac in Healthy Human Volunteers

The purpose of the present study was to assess the effect of resveratrol (RSV) treatment on the pharmacokinetics of diclofenac (DIC) in healthy human volunteers.

Targeted Delivery of Bleomycin: a Comprehensive Anticancer Review

Despite being one of the most effective broad-spectrum chemotherapeutic agents in the treatment of cancers, the clinical applications of bleomycins (BLMs) have been limited due to their poor drug delivery abilities, and the side effect of causing lung fibrosis.

Cysteine and arginine-rich peptides as molecular carriers

A number of linear and cyclic peptides containing alternative arginine and cysteine residues, namely linear (CR)3, linear (CR)4, linear (CR)5, cyclic [CR]4, and cyclic [CR]5, were synthesized.